Dalgleish A G
Department of Cellular and Molecular Sciences, St George's Hospital Medical School, London, UK.
Curr Opin Biotechnol. 1992 Dec;3(6):650-5. doi: 10.1016/0958-1669(92)90011-7.
The immunotherapy of AIDS encompasses a broad range of therapeutic possibilities. A number of stimulating and immunomodulating agents have been tried without any overt success. More recently, passive immunotherapy of AIDS using donated plasma and active therapeutic vaccine procedures have been reported. A number of clinical and laboratory observations together with preliminary results of clinical trials suggest that post-infection vaccines may be able to delay progression to disease in some individuals.
